IL112994A0 - Recombinant viruses, their preparation and their use in gene therapy - Google Patents

Recombinant viruses, their preparation and their use in gene therapy

Info

Publication number
IL112994A0
IL112994A0 IL11299495A IL11299495A IL112994A0 IL 112994 A0 IL112994 A0 IL 112994A0 IL 11299495 A IL11299495 A IL 11299495A IL 11299495 A IL11299495 A IL 11299495A IL 112994 A0 IL112994 A0 IL 112994A0
Authority
IL
Israel
Prior art keywords
preparation
gene therapy
recombinant viruses
viruses
recombinant
Prior art date
Application number
IL11299495A
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL112994A0 publication Critical patent/IL112994A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11299495A 1994-03-18 1995-03-14 Recombinant viruses, their preparation and their use in gene therapy IL112994A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403192A FR2717497B1 (en) 1994-03-18 1994-03-18 Recombinant viruses, preparation and use in gene therapy.

Publications (1)

Publication Number Publication Date
IL112994A0 true IL112994A0 (en) 1995-06-29

Family

ID=9461191

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11299495A IL112994A0 (en) 1994-03-18 1995-03-14 Recombinant viruses, their preparation and their use in gene therapy

Country Status (8)

Country Link
EP (1) EP0750674A1 (en)
JP (1) JPH09510356A (en)
AU (1) AU1896095A (en)
CA (1) CA2184408A1 (en)
FR (1) FR2717497B1 (en)
IL (1) IL112994A0 (en)
WO (1) WO1995025802A1 (en)
ZA (1) ZA952243B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270452A (en) * 1988-11-28 1993-12-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Pure glia maturation factor
FR2688514A1 (en) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
FR2704234B1 (en) * 1993-04-22 1995-07-21 Centre Nat Rech Scient RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY.

Also Published As

Publication number Publication date
CA2184408A1 (en) 1995-09-28
FR2717497A1 (en) 1995-09-22
EP0750674A1 (en) 1997-01-02
AU1896095A (en) 1995-10-09
FR2717497B1 (en) 1996-04-12
WO1995025802A1 (en) 1995-09-28
ZA952243B (en) 1996-01-09
JPH09510356A (en) 1997-10-21

Similar Documents

Publication Publication Date Title
IL111681A0 (en) Recombinant viruses and their use in gene therapy
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
ZA952563B (en) Recombinant viruses their preparation and their use in gene therapy
IL115584A0 (en) Viral vectors and their use in gene therapy
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
EP0710667A3 (en) Modified oligonucleotides, their preparation and their use
AU4032893A (en) Human papilloma virus genes and their use in gene therapy
HU9503751D0 (en) Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
ZA945012B (en) Viral vectors and their use in gene therapy
SG54275A1 (en) Dna coding for decarbamylase improved in thermostability and use thereof
IL111682A0 (en) Recombinant viruses and their use in gene therapy
AU4556597A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
IL112453A0 (en) Human repair proteins, dna(rna) encoding them and their preparation
HUP9901035A3 (en) Parapoxviruses containing foreign dna, their production and their use in vaccines
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
IL117466A0 (en) Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy
ZA952242B (en) Recombinant viruses their preparation and their use in gene therapy
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
ZA978772B (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy.
IL112992A0 (en) Recombinant viruses, their preparation and their use in gene therapy
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
IL112994A0 (en) Recombinant viruses, their preparation and their use in gene therapy
ZA952286B (en) Recombinant viruses their preparation and their use in gene therapy
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use